Active Ingredients
(In each 5 mL teaspoonful)
Brompheniramine Maleate, USP 1 mg
Dextromethorphan HBr, USP 5 mg
Phenylephrine HCl, USP 2.5 mg
The following Structured Product Label (SPL) was submitted to the FDA by Larken Laboratories, Inc. for the product Endacof Dm (NDC 68047-143). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(In each 5 mL teaspoonful)
Brompheniramine Maleate, USP 1 mg
Dextromethorphan HBr, USP 5 mg
Phenylephrine HCl, USP 2.5 mg
Brompheniramine Maleate Antihistamine
Dextromethorphan HBr Antitussive (cough suppressant)
Phenylephrine HCl Nasal decongestant
Temporarily relieves these symptoms due to hay fever (allergic rhinitis):
Do not use
Do not exceed recommended dosage.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center immediately.
Do not exceed 6 doses in a 24-hour period
| Age | Dose |
| Adults and children over 12 years of age: | 4 teaspoonsful (20 mL) every 4 hours |
| Children 6 to under 12 years of age: | 2 teaspoonsful (10 mL) every 4 hours |
| Children under 6 years of age: | Ask your doctor |
Benzoic acid, edetate disodium, FD&C Red #40, propylene glycol, purified water saccharin sodium, sorbitol solution and strawberry flavoring
Call 1-888-527-5522 weekdays from 9:00 am to 4:00 pm CST or go to http://www.larkenlabs.com.
* Please review the disclaimer below.